ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,635Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 434

$860K Total Retail Price of All Prescriptions

Rank: 7 out of 434

1,167 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,167 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 1,167 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 21,882 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 1,620 1,517 1 1
OMEPRAZOLE 1,123 1,033 2 5
SIMVASTATIN 1,107 1,036 3 2
LEVOTHYROXINE SODIUM 905 847 4 3
AMLODIPINE BESYLATE 837 805 5 6
HYDROCODONE-ACETAMINOPHEN 778 596 S3 6 4
GABAPENTIN 733 645 7 14
LOSARTAN POTASSIUM 629 605 8 13
LOVASTATIN 609 566 9 10
ATENOLOL 595 571 10 16
ALENDRONATE SODIUM 543 541 11 15
HYDROCHLOROTHIAZIDE 403 377 12 8
WARFARIN SODIUM 401 381 13 18
ATORVASTATIN CALCIUM 388 382 14 19
TERAZOSIN HCL 385 371 15 40
PRAVASTATIN SODIUM 360 337 16 17
METOPROLOL TARTRATE 359 345 17 12
METOPROLOL SUCCINATE 336 325 18 22
FINASTERIDE 315 304 19 54
VENTOLIN HFA 307 279 20 30
FUROSEMIDE 305 294 21 9
GLIPIZIDE ER 275 274 22 65
ZOLPIDEM TARTRATE 269 253 23 11
METFORMIN HCL 257 241 24 7
TAMSULOSIN HCL 244 235 25 29
POTASSIUM CHLORIDE 236 229 26 20
SERTRALINE HCL 229 211 27 27
SPIRIVA 220 212 28 36
RANITIDINE HCL 212 195 29 31
PANTOPRAZOLE SODIUM 204 177 30 66
CLOPIDOGREL 201 194 31 41
DONEPEZIL HCL 197 197 32 35
ALLOPURINOL 196 193 33 25
CARVEDILOL 193 181 34 24
METFORMIN HCL ER 189 179 35 48
FLUTICASONE PROPIONATE 185 162 36 26
QVAR 183 175 37 90
LISINOPRIL-HYDROCHLOROTHIAZIDE 174 162 38 21
LOSARTAN-HYDROCHLOROTHIAZIDE 167 167 39 39
CITALOPRAM HBR 162 145 40 23
BENAZEPRIL HCL 154 146 41 49
FLUOXETINE HCL 151 129 42 32
TRAZODONE HCL 145 132 43 33
PLAVIX 140 134 44 64
GEMFIBROZIL 129 111 45 62
ENALAPRIL MALEATE 124 112 46 59
GLYBURIDE 122 114 R 47 51
LANTUS SOLOSTAR 115 85 48 71
AMITRIPTYLINE HCL 112 89 R 49 57
NIASPAN 111 111 50 145
HYDRALAZINE HCL 110 107 51 79
FENOFIBRATE 106 104 52 43
DILTIAZEM ER 96 96 53 98
PREDNISONE 95 86 54 42
DIGOXIN 94 83 55 69
SYMBICORT 92 88 56 93
MORPHINE SULFATE ER 91 50 S2 57 50
DILTIAZEM 24HR ER 87 87 58 103
CLONIDINE HCL 87 87 58 63
OXYCODONE HCL 85 61 S2 60 34
PEN NEEDLE 84 73 61 83
GLIPIZIDE 80 73 62 37
NIFEDIPINE ER 80 80 62 86
OXYBUTYNIN CHLORIDE 79 79 64 82
POLYETHYLENE GLYCOL 3350 78 65 65 81
ISOSORBIDE MONONITRATE ER 78 77 65 68
PAROXETINE HCL 78 76 65 61
TRAMADOL HCL 75 70 68 28
TRIAMTERENE-HCTZ 74 72 69 47
VERAPAMIL ER 73 73 70 78
OXYCODONE HCL-ACETAMINOPHEN 68 43 S2 71 53
DILTIAZEM 24HR CD 64 49 72 126
ACTOS 63 59 73 85
OXYCODONE-ACETAMINOPHEN 62 58 S2 74 74
LANTUS 61 59 75 80
LEVOXYL 58 58 76 130
PROPRANOLOL HCL 56 56 77 102
GLIPIZIDE XL 56 56 77 202
ADVAIR DISKUS 55 39 79 52
IBUPROFEN 53 47 80 56
LIPITOR 52 48 81 133
FORADIL 52 52 81 215
FAMOTIDINE 50 46 83 76
SPIRONOLACTONE 50 45 83 70
ROPINIROLE HCL 50 38 83 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.